Table 2.
AGREE II mean item scores and domain percentage scores for each guideline.
| Item | Guidelinea | Overall mean score | |||||||
|
|
|
NCPIC | IPS | NICE | APA | NSWD | NSWP | NHC |
|
| Scope and purpose, mean item score |
|
|
|
|
|
|
|
|
|
|
|
Objective described | 5.75 | 3.50 | 6.50 | 6.00 | 6.50 | 6.25 | 6.50 | 5.86 |
|
|
Health question described | 6.00 | 4.25 | 6.50 | 6.25 | 6.25 | 6.50 | 5.50 | 5.89 |
|
|
Population described | 6.00 | 4.50 | 6.50 | 5.75 | 5.75 | 6.50 | 6.25 | 5.89 |
|
|
Domain score,b % | 82% | 51% | 92% | 83% | 86% | 90% | 85% | 81% |
| Stakeholder involvement, mean item score |
|
|
|
|
|
|
|
|
|
|
|
Relevant professional groups | 5.25 | 2.25 | 6.50 | 3.75 | 5.00 | 5.75 | 5.00 | 4.79 |
|
|
Target population preferences | 2.75 | 1.00 | 5.50 | 1.25 | 1.75 | 1.75 | 3.75 | 2.54 |
|
|
Target users defined | 6.75 | 3.00 | 6.25 | 5.75 | 6.75 | 6.25 | 5.50 | 5.75 |
|
|
Domain score,b % | 65% | 18% | 85% | 43% | 58% | 60% | 63% | 56% |
| Rigor of development, mean item score |
|
|
|
|
|
|
|
|
|
|
|
Systematic search | 2.25 | 1.25 | 6.75 | 6.75 | 2.25 | 5.50 | 1.50 | 3.75 |
|
|
Selection criteria described | 3.75 | 1.50 | 6.75 | 6.25 | 2.25 | 4.50 | 4.25 | 4.18 |
|
|
Strengths/limitations described | 5.00 | 1.00 | 6.75 | 6.25 | 5.50 | 5.75 | 2.00 | 4.61 |
|
|
Formulation methods described | 5.25 | 1.50 | 6.75 | 6.00 | 5.50 | 3.75 | 1.75 | 4.36 |
|
|
Risks/benefits considered | 4.75 | 1.00 | 5.25 | 5.00 | 4.75 | 5.00 | 3.00 | 4.11 |
|
|
Suggestions linked to evidence | 5.50 | 3.50 | 6.75 | 6.50 | 6.25 | 6.25 | 4.00 | 5.54 |
|
|
Externally reviewed by experts | 1.00 | 1.00 | 5.00 | 5.00 | 1.25 | 1.75 | 1.25 | 2.32 |
|
|
Procedure for updates | 3.50 | 1.00 | 6.50 | 5.00 | 4.50 | 1.75 | 1.25 | 3.36 |
|
|
Domain score,b % | 48% | 9% | 89% | 81% | 51% | 55% | 23% | 50% |
| Clarity of presentation, mean item score |
|
|
|
|
|
|
|
|
|
|
|
Specific recommendations | 6.25 | 4.00 | 6.50 | 5.50 | 5.75 | 5.25 | 4.50 | 5.39 |
|
|
Options presented | 6.50 | 3.50 | 6.50 | 6.50 | 6.25 | 6.25 | 4.00 | 5.64 |
|
|
Identifiable recommendations | 6.25 | 4.00 | 4.50 | 3.25 | 6.50 | 4.75 | 6.25 | 5.07 |
|
|
Domain score,b % | 89% | 47% | 81% | 68% | 86% | 74% | 65% | 73% |
| Applicability, mean item score |
|
|
|
|
|
|
|
|
|
|
|
Facilitators/barriers described | 4.75 | 1.25 | 3.75 | 4.75 | 3.75 | 3.25 | 3.00 | 3.50 |
|
|
Advice/tools for implementation | 6.50 | 2.00 | 6.00 | 3.25 | 4.25 | 6.00 | 4.00 | 4.57 |
|
|
Resource implications considered | 3.25 | 1.00 | 6.75 | 4.00 | 3.00 | 3.00 | 1.50 | 3.21 |
|
|
Monitoring criteria presented | 4.00 | 2.00 | 5.25 | 4.25 | 4.00 | 4.25 | 3.50 | 3.89 |
|
|
Domain score,b % | 60% | 9% | 74% | 51% | 46% | 52% | 33% | 46% |
| Editorial independence, mean item score |
|
|
|
|
|
|
|
|
|
|
|
Lack of funding body influence | 4.25 | 1.00 | 4.50 | 3.50 | 3.75 | 3.50 | 1.50 | 3.14 |
|
|
Competing interests addressed | 1.25 | 1.00 | 6.75 | 5.25 | 1.00 | 1.00 | 1.00 | 2.46 |
|
|
Domain score,b % | 29% | 0% | 77% | 56% | 23% | 21% | 4% | 30% |
| Overall guideline assessment, mean item score |
|
|
|
|
|
|
|
|
|
|
|
Overall quality | 5.50 | 2.00 | 6.00 | 4.75 | 4.50 | 5.25 | 3.50 | 4.50 |
a NCPIC: National Cannabis Prevention and Information Centre; IPS: Indian Psychiatric Society; NICE: National Institute for Health and Clinical Excellence; APA: American Psychiatric Association; NSWD: New South Wales-Drug; NSWP: New South Wales-Pregnancy; and NHC: National Health Committee.
b Domain percentage scores were derived by summing all mean individual AGREE II item scores and standardizing the total as a percentage of the maximum possible score for that domain.